Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 20/20 | 0.86 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.86 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.86 |
| ▸ | RAF1 | P04049 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25079284 | 0.99 | KRAS (0.85) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL25402404 | 0.99 | KRAS (0.85) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL30537097 | 0.99 | KRAS (0.85) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL25401994 | 0.99 | KRAS (0.86) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL25404089 | 0.97 | KRAS (0.87) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL25079349 | 0.96 | KRAS (0.84) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL25079351 | 0.96 | KRAS (0.84) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL25403081 | 0.96 | KRAS (0.84) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL25079245 | 0.96 | KRAS (0.85) | KRASMAPK3MAPK1RAF1 | |
| SCHEMBL24733226 | 0.96 | KRAS (0.83) | KRASMAPK3MAPK1RAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023173017-A1 | KRAS INHIBITORS FOR TREATING DISEASE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | claimed |
| WO-2023173017-A1 | KRAS INHIBITORS FOR TREATING DISEASE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | disclosed |
| WO-2023173017-A1 | KRAS INHIBITORS FOR TREATING DISEASE | BLOSSOMHILL THERAPEUTICS, INC. (US) | 2023-09-14 | — | — | WO | disclosed |